SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 785.12 |
| Enterprise Value ($M) | 664.24 |
| Book Value ($M) | 91.13 |
| Book Value / Share | 0.59 |
| Price / Book | 8.62 |
| NCAV ($M) | 71.31 |
| NCAV / Share | 0.46 |
| Price / NCAV | 11.01 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.46 |
| Return on Assets (ROA) | -0.63 |
| Return on Equity (ROE) | -8.31 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.59 |
| Current Ratio | 6.66 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 232.24 |
| Assets | 252.06 |
| Liabilities | 160.93 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 58.44 |
| Operating Income | -82.38 |
| Net Income | -80.74 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -70.23 |
| Cash from Investing | -6.09 |
| Cash from Financing | 169.83 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Summer Road Llc | 9.40 | 6.93 | |
| 13G/A | Opaleye Management Inc. | 5.51 | -0.08 | |
| 13G/A | Vanguard Group Inc | 4.46 | 28.70 | |
| 13G/A | BlackRock Inc. | 5.20 | 16.33 | |
| 13G | Venrock Healthcare Capital Partners III, L.P. | 6.80 | ||
| 13G | Deep Track Capital, LP | 8.38 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 266,684 | 1,895,228 | 14.07 | |
| 490,063 | 3,598,356 | 13.62 | |
| 1,353,737 | 2,668,717 | 50.73 | |
| 1,055,597 | 1,768,867 | 59.68 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NRIX – Nurix Therapeutics, Inc. | NTLA – Intellia Therapeutics, Inc. |
| OCS – Oculis Holding AG | OMER – Omeros Corporation |
| PAHC – Phibro Animal Health Corporation |